News

Newly Funded Research: Targeting Local B Cells to Prevent Chronification of Neuropathic Pain

Principal Investigators Peter Grace, PhD, from MD Anderson Cancer Center, University of Texas, and Cobi Heijnen, PhD, from Rice University, were recently granted Investigator-Initiated Research Awards. Grace received funding totaling USD$3,064,079, and Heijnen received funding totaling USD$165,704. Peripheral Neuropathy Advocacy Grace and Heijnen’s awards were made possible through the Foundation for Peripheral Neuropathy’s (FPN) advocacy …

Newly Funded Research: Targeting Local B Cells to Prevent Chronification of Neuropathic Pain Read More »

Newly Funded Research: A Novel miR-155 Therapy for the Treatment of Peripheral Neuropathy

Principal Investigator Shailly Jariwala, MS, PhD, of the Henry M. Jackson Foundation, was recently granted a Discovery Award totaling USD$319,151 for her research on a new therapy for peripheral neuropathy. Peripheral Neuropathy Advocacy Jariwala’s award was made possible through the Foundation for Peripheral Neuropathy’s (FPN) advocacy efforts with the Department of Defense’s CDMRP program. Advocacy …

Newly Funded Research: A Novel miR-155 Therapy for the Treatment of Peripheral Neuropathy Read More »

Johnson & Johnson Joins Forces with the Foundation for Peripheral Neuropathy as 2024 Impact Partner

The Foundation for Peripheral Neuropathy (FPN) is proud to announce an exciting new partnership with Johnson & Johnson, one of the world’s leading healthcare companies, as an esteemed 2024 Ambassador Impact Partner. This collaboration marks a significant milestone in FPN’s mission to advance research and education for individuals affected by peripheral neuropathy (PN). Collaboration for …

Johnson & Johnson Joins Forces with the Foundation for Peripheral Neuropathy as 2024 Impact Partner Read More »

How a PN patient maintains hope

Meet Jeff K., an FPN supporter and volunteer, recent retiree, and resident of West Hartford, CT. Jeff was diagnosed with peripheral neuropathy (PN) nine years ago, with noticeable issues emerging in the last two years. The initial diagnosis followed back surgery, and his neurosurgeon at Mass General in Boston referred him to a neurologist due …

How a PN patient maintains hope Read More »

Understanding the Connection Between Polyneuropathy and hATTR Amyloidosis

“I have to be my own advocate, and you should be too,” said Christine, living with hereditary ATTR (hATTR) amyloidosis. “Once you know something, you can deal with it head-on. It’s the ‘not knowing’ that’s the most frustrating. Knowledge is power!” Christine shared her inspiring story about being diagnosed with and living with hATTR amyloidosis …

Understanding the Connection Between Polyneuropathy and hATTR Amyloidosis Read More »

Headshot of 2024 CRTS award recipient

Clinical Research Training Scholarship Recipient Announced

The Foundation for Peripheral Neuropathy (FPN) is pleased to announce the 2024 Clinical Research Training Scholarship (CRTS) recipient for peripheral neuropathy (PN), Francesco E. Michelassi, MD, Neuromuscular Research Fellow, Columbia University Irving Medical Center. Michelassi’s research is fully funded by FPN and will focus on chemotherapy-induced peripheral neuropathy (CIPN), by studying how a chemotherapy drug …

Clinical Research Training Scholarship Recipient Announced Read More »

New PN Biobank Research Discovery!

In November 2023, a new discovery was made about neuropathic pain in patients suffering from idiopathic peripheral neuropathy. Using data from the Peripheral Neuropathy Research Registry (PNRR), the Foundation for Peripheral Neuropathy’s research consortium completed an important analysis that led to an important discovery. This research is now published in a renowned research journal. Plasma …

New PN Biobank Research Discovery! Read More »

FPN Funds IMAGiNe Study for anti-MAG Research

Through the generosity of our donors, the Foundation for Peripheral Neuropathy (FPN) was able to support the IMAGiNe study with a $165,000 research grant to fund new patient enrollment for anti-MAG neuropathy. $90,000 of these funds were spent in 2022, which resulted in over 150 new patients enrolling in the study. In 2023, an additional $27,375 was spent, …

FPN Funds IMAGiNe Study for anti-MAG Research Read More »